TMCnet News
Next Generation Sequencing (NGS) Global Market 2018-2023 to Grow at a CAGR of 20.21%DUBLIN, April 23, 2018 /PRNewswire/ -- The "Next generation Sequencing Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering. Next generation sequencing market is projected to expand at a CAGR of 20.21%, to grow from US$4.374 billion in 2017 to US$13.198 billion by 2023. The global demand for next-generation sequencing (NGS) products and services is highly driven by an increase in the application of NGS, technological advancement in NGS technology, increase in genome mapping programs, and surge in collaborations and partnerships resulting in high investments in R&D in NGS technology. The efficient replacement of traditional technologies (microarrays), cost efficiency, speed and accuracy of technology along with the rise in the application in drug discovery will aid to the global next-generation sequencing demand growth over next five years. However, lack of skilled professionals, interpretation of complex data, and legal and ethical issues are expected to hinder the NGS market growth. Major industry players profiled as part of the report are Roche Holding AG, Agilent Technologies, Thermo Fisher Scientific, Beijing Genomics Institute, GATC Biotech AG, and Pacific Bosciences of California, Inc. among others. Key Topics Covered 1. INTRODUCTION For more information about this report visit https://www.researchandmarkets.com/research/97bb78/next_generation?w=5 Media Contact: Research and Markets
View original content:http://www.prnewswire.com/news-releases/next-generation-sequencing-ngs-global-market-2018-2023-to-grow-at-a-cagr-of-20-21-300634448.html SOURCE Research and Markets |